Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2015

Mar 23, 2015

29821_dirs_2015-03-23_3cdb5be8-68e9-45d0-b5f9-35ceddca852b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-03-20

Reporting Person: Pierce David A (SVP and President, Endoscopy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-20 Common Stock M 9550.0000 $16.0200 Acquired 35150.0000 Direct
2015-03-20 Common Stock M 8500.0000 $8.3000 Acquired 43650.0000 Direct
2015-03-20 Common Stock S 18050.0000 $18.0000 Disposed 25600.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-20 Stock Option (Right to Buy) $8.3000 M 8500.0000 Disposed 2019-02-24 Common Stock (8500.0000) Direct
2015-03-20 Stock Option (Right to Buy) $16.0200 M 9550.0000 Disposed 2016-07-24 Common Stock (9550.0000) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on July 24, 2007, the first anniversary of the date of grant.